[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ct-scan\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ct-scan":67},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100607713","phase-2-evaluation-of-ct-xpi-100607713",false,"NCT07192133","Evaluation of CT-XPI","Evaluation of Computed Tomography X-ray-Pulsatility Index (CT-XPI)","Inclusion Criteria:\n\n* Age 18 years or older\n* Able to sign and date the informed consent form\n* Will undergo a clinically-indicated CT exam of the head, neck, chest, abdomen, pelvis, or extremities\n\nExclusion Criteria:\n\n* Pregnant or lactating\n* In need of urgent or emergent care\n* Have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the participant","ALL","18 Years",{"count":19,"type":20},30,"ESTIMATED","INTERVENTIONAL",[23],"PHASE2","The goal of this clinical trial is to learn if a new computed tomography (CT) lung perfusion imaging method is as effective as standard of care (SOC) CT imaging. The main question it aims to answer is:\n\n* Does the new contrast-free method provide more information about lung perfusion than SOC?\n\nParticipants will undergo a 30 minute chest CT.",[26,27],"CT Scan","Computed Tomography","RECRUITING","2026-06-09",{"date":31,"type":32},"2026-06-10","ACTUAL",{"date":34,"type":32},"2026-01-26",{"date":36,"type":20},"2026-12",{"name":38,"class":39},"University of Wisconsin, Madison","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":47,"targetDuration":4,"studyType":49,"phases":4,"briefSummary":50,"conditions":51,"keywords":54,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":4},"100625578","comparison-between-triphasic-ct-abdomen-and-eus-fnb-in-characterization-of-pancreatic-lesion-100625578","NCT07424456","Comparison Between Triphasic CT Abdomen and EUS-FNB in Characterization of Pancreatic Lesion","Inclusion Criteria:\n\n* \\*Adult patients (age\\>18 years) presenting with focal pancreatic lesions detected on initial imaging.\n\n  * Patients referred for further evaluation by triphasic CT and\u002For EUS-guided biopsy.\n  * Patients able to provide informed consent\n\nExclusion Criteria:\n\n* Previous pancreatic surgery.\n\n  * Known metastatic disease at presentation.\n  * Contraindications to contrast-enhanced CT (e.g. severe renal impairment, contrast allergy)\n  * Contraindications to EUS or biopsy (e.g., coagulopathy uncorrected, severe cardiopulmonary instability).\n  * Pregnancy.",{"count":48,"type":20},50,"OBSERVATIONAL","evaluate the relationship between triphasic CT and EUS findings and the characterization of pancreatic lesions.",[52,26,53],"EUS Guided Biopsy","Pancreatic Lesions Located at the Body or the Tail",[55,56],"Triphasic Ct abdomen vs EUS-FNB","EUS-FNB","NOT_YET_RECRUITING","2026-02-13",{"date":60,"type":32},"2026-02-20",{"date":62,"type":20},"2026-02-01",{"date":64,"type":20},"2027-04-01",{"name":66,"class":39},"Assiut University","CT-scan"]